Skip to content

Probiotics as Adjunctive Therapy in the Management of Periodontitis

Probiotics as Adjunctive Therapy in the Management of Periodontitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07531875
Enrollment
20
Registered
2026-04-15
Start date
2025-11-10
Completion date
2028-12-01
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Brief summary

The goal of this clinical trials is to learn about the effect of taking Prodentis on a long term basis following periodontal therapy. The main question it aims to answer is 1\. what is the effect of long-term consumption of Prodentis on regulating periodontal health and systemic immune-response, when compare to only taking it for 3 months post RSD?

Detailed description

Following root surface debridement (RSD), subjects in the control group (group NP) will be instructed to take Prodentis® twice/day immediately for 3 months only then continue 3 monthly review until month 12th. For subjects in the test group (group OP), following RSD, they will be instructed to take Prodentis® twice/day immediately for 3 months then continue Prodentis® once a day until month 12th. They will be reviewed 3 monthly.

Interventions

DIETARY_SUPPLEMENTProdentis

Non-surgical periodontal therapy

Sponsors

University of Malaya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. The subject has given their written consent to participate in the trial. 2. All subjects must be aged \>18 years old, not pregnant, and presented with number of teeth \> 12 3. Diagnosis for periodontitis Stage III and IV, will be according to 2017 the American Academy of Periodontology (AAP) and European Federation of Periodontology (EFP) classification 4. Has had 1 round of periodontal therapy within 3-6 months' time from recruitment date, and currently presented with at least 4 residual pockets with pocket depth 5mm and above.

Design outcomes

Primary

MeasureTime frameDescription
Periodontal pocket depthsBaseline, 3 months, 6 months and 1 yearUNC-15 probe will be used to measure this outcome

Secondary

MeasureTime frameDescription
Biomarkers from Serum and SalivaThe collection of saliva and serum will be done at baseline, 3 month and 6 months post RSD, and finally at 12 month.Serum and saliva will be collected to measure the levels of IL-6 and IL-10

Countries

Malaysia

Contacts

CONTACTCheah
chiawei@um.edu.my+60379674806
PRINCIPAL_INVESTIGATORCheah

Universiti Malaya

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026